Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Main objective : In patients with type 2 diabetes mellitus with inadequate glycemic control on diet and exercise: (1) After 24 weeks, to assess the effect of treatment with MK-0431 compared with placebo on HbA1C. (2) To assess the safety and tolerability of MK-0431.
Critère d'inclusion
- Type 2 diabetes mellitus